中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
36期
49-50
,共2页
镇肝熄风汤%福辛普利%肝阳上亢型%高血压
鎮肝熄風湯%福辛普利%肝暘上亢型%高血壓
진간식풍탕%복신보리%간양상항형%고혈압
Zhen gan Xi feng decoction%Fosinopril%Liver-Yang hyperactivity%Hypertension
目的：探讨镇肝熄风汤联合福辛普利治疗肝阳上亢型高血压的临床疗效。方法：选取我院2013年4月～2014年2月期间收治的肝阳上亢型高血压患者210例，随机分为2组，每组105例，分别予以镇肝熄风汤联合福辛普利（观察组）和福辛普利（对照组）治疗，比较两组治疗后血压、血脂水平变化和不良反应情况。结果：观察组治疗后收缩压(129.37±8.21)mmHg、舒张压(85.24±2.99)mmHg 均低于对照组，观察组治疗后 TC(4.54±0.84)mmol/L、TG(1.51±0.68)mmol/L、HDL-C(1.52±0.79)mmol/L、LDL-C(2.51±0.65)mmol/L均低于对照组治疗后，以上差异具有统计学意义（P<0.05），观察组不良反应和对照组发生人数基本持平，无统计学意义。结论：镇肝熄风汤联合福辛普利治疗肝阳上亢型高血压降压临床效果较好，血压、血脂明显改善，不增加不良反应，适合临床广泛应用。
目的：探討鎮肝熄風湯聯閤福辛普利治療肝暘上亢型高血壓的臨床療效。方法：選取我院2013年4月～2014年2月期間收治的肝暘上亢型高血壓患者210例，隨機分為2組，每組105例，分彆予以鎮肝熄風湯聯閤福辛普利（觀察組）和福辛普利（對照組）治療，比較兩組治療後血壓、血脂水平變化和不良反應情況。結果：觀察組治療後收縮壓(129.37±8.21)mmHg、舒張壓(85.24±2.99)mmHg 均低于對照組，觀察組治療後 TC(4.54±0.84)mmol/L、TG(1.51±0.68)mmol/L、HDL-C(1.52±0.79)mmol/L、LDL-C(2.51±0.65)mmol/L均低于對照組治療後，以上差異具有統計學意義（P<0.05），觀察組不良反應和對照組髮生人數基本持平，無統計學意義。結論：鎮肝熄風湯聯閤福辛普利治療肝暘上亢型高血壓降壓臨床效果較好，血壓、血脂明顯改善，不增加不良反應，適閤臨床廣汎應用。
목적：탐토진간식풍탕연합복신보리치료간양상항형고혈압적림상료효。방법：선취아원2013년4월～2014년2월기간수치적간양상항형고혈압환자210례，수궤분위2조，매조105례，분별여이진간식풍탕연합복신보리（관찰조）화복신보리（대조조）치료，비교량조치료후혈압、혈지수평변화화불량반응정황。결과：관찰조치료후수축압(129.37±8.21)mmHg、서장압(85.24±2.99)mmHg 균저우대조조，관찰조치료후 TC(4.54±0.84)mmol/L、TG(1.51±0.68)mmol/L、HDL-C(1.52±0.79)mmol/L、LDL-C(2.51±0.65)mmol/L균저우대조조치료후，이상차이구유통계학의의（P<0.05），관찰조불량반응화대조조발생인수기본지평，무통계학의의。결론：진간식풍탕연합복신보리치료간양상항형고혈압강압림상효과교호，혈압、혈지명현개선，불증가불량반응，괄합림상엄범응용。
Objective:To investigate the clinical effects of combined Zhenganxifeng decoction with fosinopril on Hyperactivity Hypertension. Method:210 hypertensive patients treated in our hospital during the April 2013 to February 2014 were randomly divided into treatment group and control group, each of 105 cases, were given Zhenganxifeng decoction and fosinopril respectively to compare blood pressure, lipid levels, and adverse effects of the two groups after treatment. Results:Systolic blood pressure was taken after treatment as (129.37 ± 8.21)mmHg, with diastolic blood pressure of (85.24 ± 2.99)mmHg, which were lower than those in the control group?the treatment group was measured TC(4.54 ± 0.84)mmol/L, TG(1.51 ± 0.68)mmol/L, HDL-C(1.52 ± 0.79)mmol/L, LDL-C(2.51 ± 0.65)were lower than those in the control group, showing statistically significant differences (P<0.05)?adverse reactions of the treatment group occurred basically the same as the control group with no significant difference. Conclusion:Zhenganxifeng decoction combined with fosinopril proves favorable effects on hyperactivity hypertension with improved blood pressure and lipids and no adverse reaction, which is worth clinical applications.
